Aug 2026
XunZi, an AI biologist, reveals disease-modifying targets.
In Parkinson's disease (PD), where complex mechanisms and limited targets hamper therapy development, XunZi identifies aberrant activation of CHK2 and IRAK4 kinases across multiple models and establishes a paradigm-shifting framework to translate fragmented biomedical knowledge and data into actionable therapeutics.
Xinhe Huang, Junhong Qin, Fei Tang et al.
· Nature Biomedical Engineerin... · 0 citations